Treatment Decisions in Unresectable HCC: Mapping Current Challenges and Emerging Opportunities

Date 28 September 2014
Event ESMO 2014
Session Bayer: Optimizing Treatment Benefits with MKIs: Understanding Who and When to Treat
Topics Anti-Cancer Agents & Biologic Therapy
Hepatobiliary Cancers
Translational Research
Presenter Jordi Bruix